Jim Eubanks, PhD, currently serves as Scientific Director at AbbVie, focusing on evidence and scientific communication strategies for tavapadon, a dopamine agonist in development for Parkinson's disease. Previously, Jim held the position of Global Director of Medical Affairs at Octave Bioscience, where responsibilities included building a Medical Affairs/MSL team and launching the Multiple Sclerosis Disease Activity test. Jim has extensive experience in clinical development and medical affairs across various companies, including Medtronic and TG Therapeutics, where significant contributions involved developing clinical study strategies and leading programs for neurological therapies. Jim's academic background includes a PhD in Neurobiology from the University of Washington and postdoctoral research at esteemed institutions like The University of Chicago and the University of Washington.
This person is not in any teams
This person is not in any offices